FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development
Open Access
- 18 February 2011
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 224 (2) , 180-189
Abstract
FBXW7 is the substrate recognition component of a SCF‐type E3 ubiquitin ligase. It has multiple targets such as Notch1, c‐Jun, and cyclin E that function in critical developmental and signalling pathways. Mutations in FBXW7 are often found in many types of cancer. In most cases, these mutations do not inactivate the protein, but are mono‐allelic missense changes at specific arginine resides involved in substrate binding. We have hypothesized that FBXW7 mutations are selected in cancers for reasons other than haploinsufficiency or full loss‐of‐function. Given that the existing mutant Fbxw7 mice carry null alleles, we created a mouse model carrying one of the commonly occurring point mutations (Fbxw7$^{R482{\rm{Q}}}$ ) in the WD40 substrate recognition domain of Fbxw7. Mice heterozygous for this mutation apparently developed normally in utero, died perinatally due to a defect in lung development, and in some cases showed cleft palate and eyelid fusion defects. By comparison, Fbxw7+/− mice were viable and developed normally. Fbxw7−/− animals died of vascular abnormalities at E10.5. We screened known FBXW7 targets for changes in the lungs of the Fbxw7R482Q/+ mice and found Tgif1 and Klf5 to be up‐regulated. Fbxw7$^{R482{\rm{Q}}}$ alleles are not functionally equivalent to heterozygous or homozygous null alleles, and we propose that they are selected in tumourigenesis because they cause a selective or partial loss of FBXW7 function. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 44 references indexed in Scilit:
- WD40 Repeat Propellers Define a Ubiquitin-Binding Domain that Regulates Turnover of F Box ProteinsMolecular Cell, 2010
- F-box and WD Repeat Domain-Containing 7 Regulates Intestinal Cell Lineage Commitment and Is a Haploinsufficient Tumor SuppressorGastroenterology, 2010
- The Fbxw7/hCdc4 tumor suppressor in human cancerCancer Letters, 2008
- Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7Oncogene, 2008
- Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7Journal of Experimental Medicine, 2008
- FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiationNature Reviews Cancer, 2008
- FBXW7/hCDC4 Is a General Tumor Suppressor in Human CancerCancer Research, 2007
- Mechanisms of Tumor Suppression by the SCFFbw7Cell Cycle, 2005
- Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor geneNature, 2004
- Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replicationNature, 2001